Avidity Partners Management as of Sept. 30, 2022
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 97 positions in its portfolio as reported in the September 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Eli Lilly & Co. (LLY) | 6.6 | $326M | 1.0M | 323.35 | |
Spdr Ser Tr Call Call Option | 6.5 | $321M | 4.1M | 79.32 | |
United Therapeutics Corporation (UTHR) | 4.1 | $203M | 970k | 209.38 | |
Neurocrine Biosciences (NBIX) | 4.0 | $197M | 1.9M | 106.21 | |
Arvinas Ord (ARVN) | 3.9 | $193M | 4.3M | 44.49 | |
Argenx Se Sponsored Adr (ARGX) | 3.5 | $174M | 492k | 353.05 | |
Biogen Idec (BIIB) | 3.3 | $160M | 600k | 267.00 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 3.0 | $149M | 513k | 289.54 | |
Syndax Pharmaceuticals (SNDX) | 2.7 | $134M | 5.6M | 24.03 | |
Prothena Corp SHS (PRTA) | 2.4 | $119M | 2.0M | 60.63 | |
Spdr Ser Tr S&p Biotech (XBI) | 2.4 | $117M | 1.5M | 79.32 | |
Acadia Healthcare (ACHC) | 2.2 | $109M | 1.4M | 78.18 | |
Akero Therapeutics (AKRO) | 2.2 | $106M | 3.1M | 34.05 | |
Sarepta Therapeutics (SRPT) | 2.1 | $105M | 948k | 110.54 | |
Humana (HUM) | 2.1 | $103M | 212k | 485.19 | |
Boston Scientific Corporation (BSX) | 2.0 | $98M | 2.5M | 38.73 | |
Immunocore Hldgs Ads (IMCR) | 2.0 | $98M | 2.1M | 46.94 | |
Karuna Therapeutics Ord | 2.0 | $97M | 432k | 224.93 | |
Anthem (ELV) | 1.9 | $94M | 208k | 454.24 | |
Horizon Therapeutics Pub L SHS | 1.9 | $92M | 1.5M | 61.89 | |
Zentalis Pharmaceuticals (ZNTL) | 1.9 | $92M | 4.2M | 21.66 | |
Avantor (AVTR) | 1.8 | $89M | 4.5M | 19.60 | |
Ultragenyx Pharmaceutical (RARE) | 1.7 | $85M | 2.1M | 41.41 | |
Natera (NTRA) | 1.5 | $76M | 1.7M | 43.82 | |
Axsome Therapeutics (AXSM) | 1.4 | $69M | 1.5M | 44.62 | |
Catalent (CTLT) | 1.4 | $68M | 940k | 72.36 | |
Intra Cellular Therapies (ITCI) | 1.3 | $65M | 1.4M | 46.53 | |
Seagen | 1.2 | $61M | 446k | 136.83 | |
Bio Rad Labs Cl A (BIO) | 1.2 | $60M | 145k | 417.14 | |
Alnylam Pharmaceuticals (ALNY) | 1.2 | $58M | 289k | 200.16 | |
Apellis Pharmaceuticals (APLS) | 1.2 | $58M | 844k | 68.30 | |
Intellia Therapeutics (NTLA) | 1.1 | $56M | 999k | 55.96 | |
Ideaya Biosciences (IDYA) | 1.1 | $55M | 3.7M | 14.92 | |
Kezar Life Sciences (KZR) | 0.9 | $47M | 5.4M | 8.61 | |
Bellus Health Com New | 0.9 | $46M | 4.3M | 10.56 | |
Revolution Medicines (RVMD) | 0.9 | $46M | 2.3M | 19.72 | |
Avidity Biosciences Ord (RNA) | 0.9 | $43M | 2.6M | 16.33 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.9 | $42M | 318k | 133.29 | |
Zai Lab Adr (ZLAB) | 0.9 | $42M | 1.2M | 34.20 | |
Arrowhead Pharmaceuticals (ARWR) | 0.8 | $42M | 1.3M | 33.05 | |
Pliant Therapeutics (PLRX) | 0.8 | $41M | 2.0M | 20.89 | |
Dex (DXCM) | 0.8 | $38M | 468k | 80.54 | |
Stryker Corporation (SYK) | 0.8 | $37M | 185k | 202.54 | |
Verve Therapeutics (VERV) | 0.7 | $36M | 1.0M | 34.35 | |
Altimmune Com New (ALT) | 0.7 | $34M | 2.7M | 12.77 | |
Centene Corporation (CNC) | 0.7 | $34M | 432k | 77.81 | |
Caribou Biosciences (CRBU) | 0.7 | $34M | 3.2M | 10.55 | |
Astrazeneca Sponsored Adr (AZN) | 0.6 | $31M | 563k | 54.84 | |
Ngm Biopharmaceuticals (NGM) | 0.5 | $24M | 1.8M | 13.08 | |
Deciphera Pharmaceuticals (DCPH) | 0.4 | $22M | 1.2M | 18.50 | |
Point Biopharma Global | 0.4 | $22M | 2.8M | 7.73 | |
Phathom Pharmaceuticals (PHAT) | 0.4 | $21M | 1.9M | 11.08 | |
Cogent Biosciences (COGT) | 0.4 | $20M | 1.4M | 14.92 | |
Nkarta (NKTX) | 0.4 | $19M | 1.4M | 13.16 | |
Beigene Sponsored Adr (BGNE) | 0.4 | $18M | 132k | 134.82 | |
Si-bone (SIBN) | 0.4 | $17M | 997k | 17.46 | |
Gossamer Bio (GOSS) | 0.4 | $17M | 1.5M | 11.98 | |
Cytokinetics Com New (CYTK) | 0.3 | $16M | 335k | 48.45 | |
Arcutis Biotherapeutics (ARQT) | 0.3 | $15M | 795k | 19.11 | |
Vaxcyte (PCVX) | 0.3 | $15M | 629k | 24.00 | |
Alphatec Hldgs Com New (ATEC) | 0.3 | $15M | 1.7M | 8.74 | |
Kinnate Biopharma (KNTE) | 0.3 | $15M | 1.2M | 11.95 | |
Iovance Biotherapeutics (IOVA) | 0.3 | $13M | 1.4M | 9.58 | |
An2 Therapeutics (ANTX) | 0.3 | $13M | 743k | 17.38 | |
Century Therapeutics (IPSC) | 0.3 | $13M | 1.3M | 9.89 | |
Transmedics Group (TMDX) | 0.3 | $13M | 300k | 41.74 | |
Sangamo Biosciences (SGMO) | 0.2 | $12M | 2.4M | 4.90 | |
Stoke Therapeutics (STOK) | 0.2 | $11M | 891k | 12.84 | |
Seaspine Holdings | 0.2 | $11M | 2.0M | 5.68 | |
Nanostring Technologies (NSTGQ) | 0.2 | $8.9M | 698k | 12.77 | |
Erasca (ERAS) | 0.2 | $7.7M | 983k | 7.80 | |
Alpine Immune Sciences (ALPN) | 0.1 | $7.2M | 999k | 7.20 | |
Surgery Partners (SGRY) | 0.1 | $6.3M | 268k | 23.40 | |
Syros Pharmaceuticals Com New (SYRS) | 0.1 | $5.8M | 900k | 6.44 | |
Caremax Com Cl A | 0.1 | $5.4M | 755k | 7.09 | |
Medicus Sciences Acquisition Cl A Shs | 0.1 | $5.1M | 520k | 9.90 | |
Bcls Acquisition Corp Com Cl A | 0.1 | $5.0M | 500k | 10.02 | |
Graphite Bio | 0.1 | $5.0M | 1.6M | 3.17 | |
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.1 | $5.0M | 500k | 9.91 | |
Panacea Acquisition Corp Ii Cl A Shs | 0.1 | $4.9M | 500k | 9.80 | |
Compass Therapeutics (CMPX) | 0.1 | $4.6M | 2.0M | 2.28 | |
Essa Pharma Com New (EPIX) | 0.1 | $4.5M | 2.5M | 1.82 | |
Health Sciences Acq Corp 2 Ord Shs | 0.1 | $4.0M | 400k | 9.90 | |
Cyteir Therapeutics | 0.1 | $3.5M | 1.8M | 1.92 | |
Tango Therapeutics (TNGX) | 0.1 | $2.9M | 814k | 3.62 | |
Scynexis Com New (SCYX) | 0.1 | $2.7M | 1.1M | 2.40 | |
Social Cap Suvretta Hlds Cp Class A Ord Shs | 0.0 | $2.0M | 200k | 9.82 | |
Social Cap Suvretta Hlds Crp Class A Ord Shs | 0.0 | $2.0M | 200k | 9.80 | |
Oncosec Medical Incorporated | 0.0 | $1.4M | 2.9M | 0.49 | |
Hyperfine Com Cl A (HYPR) | 0.0 | $1.2M | 1.5M | 0.81 | |
Ac Immune Sa SHS (ACIU) | 0.0 | $869k | 275k | 3.16 | |
Reunion Neuroscience | 0.0 | $851k | 595k | 1.43 | |
Sema4 Holdings Corp Com Cl A | 0.0 | $834k | 950k | 0.88 | |
Phasebio Pharmaceuticals (PHASQ) | 0.0 | $768k | 4.4M | 0.18 | |
Science 37 Holdings | 0.0 | $692k | 430k | 1.61 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $18k | 100k | 0.18 | |
Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $999.421000 | 58k | 0.02 |